Literature DB >> 2643968

Altered vascular reactivity in sickle hemoglobinopathy. A possible protective factor from hypertension.

F E Hatch1, L R Crowe, D E Miles, J P Young, M E Portner.   

Abstract

Patients with sickle cell anemia have considerably less hypertension than the black population in general. Factor(s) offering "protection" from hypertension in these patients remain unknown. Hormonal and hemodynamic parameters involved in blood pressure regulation were evaluated in normotensive, stable sickle cell patients and black nonsickle normotensive controls. There was no difference in systolic, diastolic, or mean arterial blood pressure between the two groups. The characteristic hemodynamic findings of increased cardiac index, renal plasma flow, and plasma volume were observed in the sickle cell patients. Urinary sodium excretion was comparable on an ad libitum, high sodium, and low sodium diet. In contrast, plasma renin activity was greater in sickle cell patients at all levels of sodium intake in both supine and upright positions. These findings suggested possible altered vascular responsiveness to endogenous angiotensin II. Plethysmography revealed that sickle cell patients had greater forearm blood flow than normal controls and black nonsickle chronic anemic controls at rest, during cold stimulation, and during exercise. Forearm vascular resistance was significantly lower in the patients and did not increase with cold-induced, sympathetic-mediated stimulation. To assess these findings more directly, the pressor response to the exogenous administration of graded doses of angiotensin II and norepinephrine was measured. There was a marked decrease in the pressor response to angiotensin II but not to norepinephrine in the sickle cell patients. The findings in these studies indicate fundamental differences in blood pressure control in the sickle cell patient, probably at the vascular level.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2643968     DOI: 10.1093/ajh/2.1.2

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  14 in total

1.  Reaping of nitric oxide by sickle cell disease.

Authors:  Jack R Lancaster
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

2.  Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice.

Authors:  Dhananjay K Kaul; Xiao-du Liu; Hee-Yoon Chang; Ronald L Nagel; Mary E Fabry
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

Review 3.  Current concerns in haematology. 1. Is the painful crisis of sickle cell disease a "steal" syndrome?

Authors:  G R Serjeant; R M Chalmers
Journal:  J Clin Pathol       Date:  1990-10       Impact factor: 3.411

4.  Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease.

Authors:  M Aslan; T M Ryan; B Adler; T M Townes; D A Parks; J A Thompson; A Tousson; M T Gladwin; R P Patel; M M Tarpey; I Batinic-Haberle; C R White; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

5.  Abnormalities in aortic properties: a potential link between left ventricular diastolic function and ventricular-aortic coupling in sickle cell disease.

Authors:  Emilie Bollache; Nadjia Kachenoura; Roberto M Lang; Ankit A Desai; Victor Mor-Avi; Amit R Patel
Journal:  Int J Cardiovasc Imaging       Date:  2016-02-23       Impact factor: 2.357

6.  Daily variability in resting levels of cardiovascular variables in normal subjects and those with homozygous sickle cell disease.

Authors:  J S Mohan; J M Marshall; H L Reid; G R Serjeant
Journal:  Clin Auton Res       Date:  1995-06       Impact factor: 4.435

7.  Decades after the cooperative study: a re-examination of systemic blood pressure in sickle cell disease.

Authors:  Payal C Desai; Allison M Deal; Julia E Brittain; Susan Jones; Alan Hinderliter; Kenneth I Ataga
Journal:  Am J Hematol       Date:  2012-06-20       Impact factor: 10.047

8.  Sickle erythrocytes, after sickling, regulate the expression of the endothelin-1 gene and protein in human endothelial cells in culture.

Authors:  M Phelan; S P Perrine; M Brauer; D V Faller
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

9.  Arterial Stiffness and Peripheral and Central Blood Pressure in Patients With Sickle Cell Disease.

Authors:  Maria Pikilidou; Maria Yavropoulou; Maria Antoniou; Eleftherios Papakonstantinou; Despoina Pantelidou; Panagiota Chalkia; Peter Nilsson; John Yovos; Pantelis Zebekakis
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-05-20       Impact factor: 3.738

10.  Genome-wide meta-analysis of systolic blood pressure in children with sickle cell disease.

Authors:  Pallav Bhatnagar; Emily Barron-Casella; Christopher J Bean; Jacqueline N Milton; Clinton T Baldwin; Martin H Steinberg; Michael Debaun; James F Casella; Dan E Arking
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.